Acute Graft-versus-Host Disease Market Size, Trends, and Growth Analysis 2026-2033 The acute graft-versus-host disease (aGvHD) industry is witnessing steady advancements driven by innovations in therapeutic approaches and an increasing prevalence of hematopoietic stem cell transplantation procedures. With rising clinical needs and evolving patient management protocols, this market is positioned for sustained growth aligned with emerging market trends and expanding treatment options. Market Size and Overview The Global Acute Graft-versus-Host Disease Market is estimated to be valued at USD 4.07 Bn in 2025 and is expected to reach USD 5.46 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.3% from 2025 to 2032. https://www.coherentmi.com/industry-reports/acute-graft-versus-host-disease-market